Common non-antibiotic drugs enhance selection for antimicrobial resistance in mixture with ciprofloxacin

  21 October 2025

This study shows that antimicrobial resistance (AMR) can be promoted not only by antibiotics but also by mixtures of antibiotics and non-antibiotic drugs (NADs). Researchers tested three NADs in combination with the antibiotic ciprofloxacin and found that these mixtures changed how resistance developed and altered microbial community composition. Compared to ciprofloxacin alone, the combinations more strongly selected for certain AMR genes (e.g., qnrB and intI1). The findings highlight that real-world drug mixtures can enhance AMR selection, and future research should account for interactions between antibiotics and NADs when assessing drivers of resistance.

Further reading: ISME Communications
Author(s): April Hayes et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!